Success Metrics

Clinical Success Rate
78.4%

Based on 29 completed trials

Completion Rate
78%(29/37)
Active Trials
3(7%)
Results Posted
28%(8 trials)
Terminated
8(18%)

Phase Distribution

Ph phase_2
6
14%
Ph phase_3
2
5%
Ph not_applicable
6
14%
Ph phase_4
9
20%
Ph early_phase_1
1
2%
Ph phase_1
18
41%

Phase Distribution

19

Early Stage

6

Mid Stage

11

Late Stage

Phase Distribution42 total trials
Early Phase 1First-in-human
1(2.4%)
Phase 1Safety & dosage
18(42.9%)
Phase 2Efficacy & side effects
6(14.3%)
Phase 3Large-scale testing
2(4.8%)
Phase 4Post-market surveillance
9(21.4%)
N/ANon-phased studies
6(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.3%

29 of 38 finished

Non-Completion Rate

23.7%

9 ended early

Currently Active

3

trials recruiting

Total Trials

44

all time

Status Distribution
Active(3)
Completed(29)
Terminated(9)
Other(3)

Detailed Status

Completed29
Terminated8
Recruiting3
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
44
Active
3
Success Rate
78.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.4%)
Phase 118 (42.9%)
Phase 26 (14.3%)
Phase 32 (4.8%)
Phase 49 (21.4%)
N/A6 (14.3%)

Trials by Status

recruiting37%
unknown37%
terminated818%
withdrawn12%
completed2966%

Recent Activity

Clinical Trials (44)

Showing 20 of 44 trialsScroll for more
NCT00162474Not Applicable

Determinants of Warfarin Metabolism

Recruiting
NCT07066722Phase 1

A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults

Completed
NCT06719557Phase 1

A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008)

Completed
NCT06906809Phase 1

Effect of Phenytoin or Itraconazole on How BGB-16673 is Absorbed and Removed From the Body in Healthy Participants

Completed
NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed
NCT06919991Phase 1

Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

Completed
NCT07072624Phase 4

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Recruiting
NCT06903715Phase 1

A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)

Completed
NCT06543043Phase 1

A Study to Evaluate the Effects of Phenytoin and Itraconazole on Sonrotoclax (BGB-11417) in Healthy Volunteers

Completed
NCT04845646Phase 1

DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.

Completed
NCT05901714Phase 1

A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam

Completed
NCT05637086Phase 2

Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

Recruiting
NCT05995249Phase 1

A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

Completed
NCT06067412Not Applicable

Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad

Completed
NCT01478035Phase 4

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

Terminated
NCT05697614Phase 4

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

Unknown
NCT01730313Phase 2

Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012

Withdrawn
NCT03632915

Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed
NCT04981704Phase 1

A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants

Completed
NCT00581893Phase 4

Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
44